Clinical trial

A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of…

NCT00363194 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00363194
Title A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients
Official title An Open-Label, Two-Period, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Single Doses of Pazopanib in Cancer Patients
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Carcinoma, Renal Cell
Intervention type Drug
Interventions Pazopanib (GW786034)
Enrollment 28
Start date Sep 21, 2006
Primary completion Jun 19, 2009
Completion Jun 19, 2009
First posted Aug 15, 2006
Last update posted Nov 17, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies